PI3 antibody (AA 61-117) (Cy5.5)
Quick Overview for PI3 antibody (AA 61-117) (Cy5.5) (ABIN717661)
Target
See all PI3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 61-117
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SKALP/Elafin
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- PI3 (Peptidase Inhibitor 3, Skin-Derived (PI3))
-
Alternative Name
- SKALP
-
Background
-
Synonyms: ELAF_HUMAN, Elafin, Elastase Specic Inhibitor, Elastase-specic inhibitor, ES 1, ESI, Peptidase inhibitor 3, PI 3, PI-3, PI3, Protease inhibitor 3 skin derived, Protease inhibitor WAP3, SKALP, Skin derived Anti leukoproteinase, Skin-derived antileukoproteinase, Trappin 2, WAP four disulfide core domain protein 14, WAP four-disulfide core domain protein 14, WFDC14.
Background: SKALP
Target
-